172 related articles for article (PubMed ID: 38600625)
41. Good practice recommendations on add-ons in reproductive medicine†.
; Lundin K; Bentzen JG; Bozdag G; Ebner T; Harper J; Le Clef N; Moffett A; Norcross S; Polyzos NP; Rautakallio-Hokkanen S; Sfontouris I; Sermon K; Vermeulen N; Pinborg A
Hum Reprod; 2023 Nov; 38(11):2062-2104. PubMed ID: 37747409
[TBL] [Abstract][Full Text] [Related]
42. ESHRE guideline: endometriosis.
Becker CM; Bokor A; Heikinheimo O; Horne A; Jansen F; Kiesel L; King K; Kvaskoff M; Nap A; Petersen K; Saridogan E; Tomassetti C; van Hanegem N; Vulliemoz N; Vermeulen N;
Hum Reprod Open; 2022; 2022(2):hoac009. PubMed ID: 35350465
[TBL] [Abstract][Full Text] [Related]
43. Weight reduction intervention for obese infertile women prior to IVF: a randomized controlled trial.
Einarsson S; Bergh C; Friberg B; Pinborg A; Klajnbard A; Karlström PO; Kluge L; Larsson I; Loft A; Mikkelsen-Englund AL; Stenlöf K; Wistrand A; Thurin-Kjellberg A
Hum Reprod; 2017 Aug; 32(8):1621-1630. PubMed ID: 28854592
[TBL] [Abstract][Full Text] [Related]
44. Septum resection versus expectant management in women with a septate uterus: an international multicentre open-label randomized controlled trial.
Rikken JFW; Kowalik CR; Emanuel MH; Bongers MY; Spinder T; Jansen FW; Mulders AGMGJ; Padmehr R; Clark TJ; van Vliet HA; Stephenson MD; van der Veen F; Mol BWJ; van Wely M; Goddijn M
Hum Reprod; 2021 Apr; 36(5):1260-1267. PubMed ID: 33793794
[TBL] [Abstract][Full Text] [Related]
45. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
46. Economic evaluation of endometrial scratching before the second IVF/ICSI treatment: a cost-effectiveness analysis of a randomized controlled trial (SCRaTCH trial).
van Hoogenhuijze NE; van Eekelen R; Mol F; Schipper I; Groenewoud ER; Traas MAF; Janssen CAH; Teklenburg G; de Bruin JP; van Oppenraaij RHF; Maas JWM; Moll E; Fleischer K; van Hooff MHA; de Koning CH; Cantineau AEP; Lambalk CB; Verberg M; van Heusden AM; Manger AP; van Rumste MME; van der Voet LF; Pieterse QD; Visser J; Brinkhuis EA; den Hartog JE; Glas MW; Klijn NF; van der Zanden M; Bandell ML; Boxmeer JC; van Disseldorp J; Smeenk J; van Wely M; Eijkemans MJC; Torrance HL; Broekmans FJM
Hum Reprod; 2022 Jan; 37(2):254-263. PubMed ID: 34864993
[TBL] [Abstract][Full Text] [Related]
47. Age-related natural fertility outcomes in women over 35 years: a systematic review and individual participant data meta-analysis.
Chua SJ; Danhof NA; Mochtar MH; van Wely M; McLernon DJ; Custers I; Lee E; Dreyer K; Cahill DJ; Gillett WR; Righarts A; Strandell A; Rantsi T; Schmidt L; Eijkemans MJC; Mol BWJ; van Eekelen R
Hum Reprod; 2020 Aug; 35(8):1808-1820. PubMed ID: 32696041
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic Accuracy Study Comparing Hysterosalpingo-Foam Sonography and Hysterosalpingography for Fallopian Tube Patency Assessment.
Ramos J; Caligara C; Santamaría-López E; González-Ravina C; Prados N; Carranza F; Blasco V; Fernández-Sánchez M
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575278
[TBL] [Abstract][Full Text] [Related]
49. BEYOND: a randomized controlled trial comparing efficacy and safety of individualized follitropin delta dosing in a GnRH agonist versus antagonist protocol during the first ovarian stimulation cycle.
Lobo R; Soerdal T; Ekerhovd E; Cohlen B; Porcu E; Schenk M; Shufaro Y; Smeenk J; Suerdieck MB; Pinton P; Pinborg A;
Hum Reprod; 2024 May; ():. PubMed ID: 38723189
[TBL] [Abstract][Full Text] [Related]
50. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
van Eekelen R; Wang R; Danhof NA; Mol F; Mochtar M; Mol BW; van Wely M
Hum Reprod; 2021 Apr; 36(5):1288-1295. PubMed ID: 33615360
[TBL] [Abstract][Full Text] [Related]
51. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
[TBL] [Abstract][Full Text] [Related]
52. Intracervical insemination versus intrauterine insemination with cryopreserved donor sperm in the natural cycle: a randomized controlled trial.
Kop PAL; van Wely M; Nap A; Soufan AT; de Melker AA; Mol BWJ; Bernardus RE; De Brucker M; Janssens PMW; Pieters JJPM; Repping S; van der Veen F; Mochtar MH
Hum Reprod; 2022 May; 37(6):1175-1182. PubMed ID: 35459949
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
van Eekelen R; Eijkemans MJ; Mochtar M; Mol F; Mol BW; Groen H; van Wely M
Hum Reprod; 2020 Sep; 35(9):2037-2046,. PubMed ID: 32876323
[TBL] [Abstract][Full Text] [Related]
54. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
[TBL] [Abstract][Full Text] [Related]
55. Is home-based monitoring of ovulation to time frozen embryo transfer a cost-effective alternative for hospital-based monitoring of ovulation? Study protocol of the multicentre, non-inferiority Antarctica-2 randomised controlled trial.
Zaat TR; de Bruin JP; Goddijn M; van Baal M; Benneheij EB; Brandes EM; Broekmans F; Cantineau AEP; Cohlen B; van Disseldorp J; Gielen SCJP; Groenewoud ER; van Heusden A; Kaaijk EM; Koks C; de Koning CH; Klijn NF; Lambalk CB; van der Linden PJQ; Manger P; van Oppenraaij RHF; Pieterse Q; Smeenk J; Visser J; van Wely M; Mol F
Hum Reprod Open; 2021; 2021(4):hoab035. PubMed ID: 35692982
[TBL] [Abstract][Full Text] [Related]
56. First experiences with hysterosalpingo-foam sonography (HyFoSy) for office tubal patency testing.
Emanuel MH; van Vliet M; Weber M; Exalto N
Hum Reprod; 2012 Jan; 27(1):114-7. PubMed ID: 22064649
[TBL] [Abstract][Full Text] [Related]
57. A large observational data study supporting the PROsPeR score classification in poor ovarian responders according to live birth outcome.
Lehert P; Arvis P; Avril C; Massin N; Parinaud J; Porcu G; Rongières C; Sagot P; Wainer R; D'Hooghe T
Hum Reprod; 2021 May; 36(6):1600-1610. PubMed ID: 33860313
[TBL] [Abstract][Full Text] [Related]
58. Gonadotrophins or clomiphene citrate in women with normogonadotropic anovulation and CC failure: does the endometrium matter?
Bordewijk EM; Weiss NS; Nahuis MJ; Kwee J; Lambeek AF; van Unnik GA; Vrouenraets FPJ; Cohlen BJ; van de Laar-van Asseldonk TAM; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
Hum Reprod; 2020 Jun; 35(6):1319-1324. PubMed ID: 32585686
[TBL] [Abstract][Full Text] [Related]
59. The effectiveness of immediate versus delayed tubal flushing with oil-based contrast in women with unexplained infertility (H2Oil-timing study): study protocol of a randomized controlled trial.
Kamphuis D; Rosielle K; van Welie N; Roest I; van Dongen AJCM; Brinkhuis EA; Bourdrez P; Mozes A; Verhoeve HR; van der Ham DP; Vrouenraets FPJM; Risseeuw JJ; van de Laar T; Janse F; den Hartog JE; de Hundt M; Hooker AB; Huppelschoten AG; Pieterse QD; Bongers MY; Stoker J; Koks CAM; Lambalk CB; Hemingway A; Li W; Mol BWJ; Dreyer K; Mijatovic V
BMC Womens Health; 2023 May; 23(1):233. PubMed ID: 37149639
[TBL] [Abstract][Full Text] [Related]
60. Clinical Aspects of HyFoSy as Tubal Patency Test in Subfertility Workup.
Exalto N; Emanuel MH
Biomed Res Int; 2019; 2019():4827376. PubMed ID: 31360713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
